Safety and Efficacy of PC945 (Opelconazole) in Combination With Other Antifungal Therapy for the Treatment of Refractory Invasive Pulmonary Aspergillosis (OPERA-T Study)
Clinical trial NCT05238116 · TERMINATED
Trial details
- NCT number
- NCT05238116
- Sponsor
- Pulmocide Ltd
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-14
- Primary completion
- 2025-12-29
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.